Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526420 · ClinicalTrials.gov registry record · Phase 2
Versartis International Trial in Adults With Long-Acting Growth Hormone
A Phase 2 study, sponsored by Versartis.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT02526420 is a Phase 2 study that has completed, run by Versartis. The registered enrollment target is 36 participants.
The verdict
NCT02526420, a Phase 2 study, has completed, sponsored by Versartis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
A Phase 2, open-label dose-finding safety study of individualized monthly VRS-317 dosing for five months in adults with GHD.
Interventions
- DRUG somavaratan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526420
The ClinicalTrials.gov registry entry for NCT02526420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Versartis, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which somavaratan is the first listed.
NCT02526420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02526420 about?
NCT02526420 is a clinical study titled "Versartis International Trial in Adults With Long-Acting Growth Hormone". A Phase 2, open-label dose-finding safety study of individualized monthly VRS-317 dosing for five months in adults with GHD.
What is the current status of trial NCT02526420?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2015-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02526420?
The interventions under investigation include: somavaratan (DRUG).
Who is sponsoring clinical trial NCT02526420?
This trial is sponsored by Versartis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.